Hansa Biopharma AB (24H.STU) Q2 2026 Earnings

23AprConfirmed
Q1 2026
Q2 2026
-0.17
-0.16
-0.14
-0.13

Details

Expected EPS
-0.130572347095372
Actual EPS
-0.17376429988
Surprise EPS
-0.04
Surprise Percent
+33.08%

Description

Hansa Biopharma AB (24H.STU) has reported earnings of -0.17376429988 per share for Q2 2026.

0 Comments

Share your thoughts